Overview

The Research of Standard Diagnosis and Treatment for Severe HSP in Children

Status:
Recruiting
Trial end date:
2020-07-01
Target enrollment:
Participant gender:
Summary
This study is performed to evaluate the efficacy and safety of various measures in the treatment of severe HSP in children.
Phase:
Phase 2
Details
Lead Sponsor:
Nanjing Children's Hospital
Treatments:
BB 1101
Dexamethasone
Dexamethasone 21-phosphate
Dexamethasone acetate
gamma-Globulins
Immunoglobulins, Intravenous
Rho(D) Immune Globulin